REC-164067

N/A

Report date: 2023/12/19 14:32:09
NME

Base Information

Drug NameREC-164067
Drug Alias NameREC-164067
ClassificationOther
Mechanisms of ActionCeramide glucosyltransferase inhibitors
TargetsCeramide glucosyltransferase
Therapy Area/IndicationsInflammationClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRecursion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A